Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

S. Saadatmand, I.M. Obdeijn, E.J. Rutgers, J.C. Oosterwijk, R.A. Tollenaar, G.H. Woldringh, E. Bergers, C. Verhoef, E.A. Heijnsdijk, M.J. Hooning, H.J. Koning, M.M. Tilanus-Linthorst

Research output: Contribution to journalArticleAcademicpeer-review

Original languageUndefined/Unknown
Pages (from-to)1729-1738
JournalInternational Journal of Cancer
Volume137
Issue number7
DOIs
Publication statusPublished - 2015

Cite this

Saadatmand, S., Obdeijn, I. M., Rutgers, E. J., Oosterwijk, J. C., Tollenaar, R. A., Woldringh, G. H., ... Tilanus-Linthorst, M. M. (2015). Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). International Journal of Cancer, 137(7), 1729-1738. https://doi.org/10.1002/ijc.29534
Saadatmand, S. ; Obdeijn, I.M. ; Rutgers, E.J. ; Oosterwijk, J.C. ; Tollenaar, R.A. ; Woldringh, G.H. ; Bergers, E. ; Verhoef, C. ; Heijnsdijk, E.A. ; Hooning, M.J. ; Koning, H.J. ; Tilanus-Linthorst, M.M. / Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). In: International Journal of Cancer. 2015 ; Vol. 137, No. 7. pp. 1729-1738.
@article{64225b52f6874329a24efba524faffc1,
title = "Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)",
author = "S. Saadatmand and I.M. Obdeijn and E.J. Rutgers and J.C. Oosterwijk and R.A. Tollenaar and G.H. Woldringh and E. Bergers and C. Verhoef and E.A. Heijnsdijk and M.J. Hooning and H.J. Koning and M.M. Tilanus-Linthorst",
year = "2015",
doi = "10.1002/ijc.29534",
language = "Undefined/Unknown",
volume = "137",
pages = "1729--1738",
journal = "International Journal of Cancer",
issn = "0020-7136",
publisher = "Wiley-Liss Inc.",
number = "7",

}

Saadatmand, S, Obdeijn, IM, Rutgers, EJ, Oosterwijk, JC, Tollenaar, RA, Woldringh, GH, Bergers, E, Verhoef, C, Heijnsdijk, EA, Hooning, MJ, Koning, HJ & Tilanus-Linthorst, MM 2015, 'Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)' International Journal of Cancer, vol. 137, no. 7, pp. 1729-1738. https://doi.org/10.1002/ijc.29534

Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). / Saadatmand, S.; Obdeijn, I.M.; Rutgers, E.J.; Oosterwijk, J.C.; Tollenaar, R.A.; Woldringh, G.H.; Bergers, E.; Verhoef, C.; Heijnsdijk, E.A.; Hooning, M.J.; Koning, H.J.; Tilanus-Linthorst, M.M.

In: International Journal of Cancer, Vol. 137, No. 7, 2015, p. 1729-1738.

Research output: Contribution to journalArticleAcademicpeer-review

TY - JOUR

T1 - Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC)

AU - Saadatmand, S.

AU - Obdeijn, I.M.

AU - Rutgers, E.J.

AU - Oosterwijk, J.C.

AU - Tollenaar, R.A.

AU - Woldringh, G.H.

AU - Bergers, E.

AU - Verhoef, C.

AU - Heijnsdijk, E.A.

AU - Hooning, M.J.

AU - Koning, H.J.

AU - Tilanus-Linthorst, M.M.

PY - 2015

Y1 - 2015

U2 - 10.1002/ijc.29534

DO - 10.1002/ijc.29534

M3 - Article

VL - 137

SP - 1729

EP - 1738

JO - International Journal of Cancer

JF - International Journal of Cancer

SN - 0020-7136

IS - 7

ER -

Saadatmand S, Obdeijn IM, Rutgers EJ, Oosterwijk JC, Tollenaar RA, Woldringh GH et al. Survival benefit in women with BRCA1 mutation or familial risk in the MRI screening study (MRISC). International Journal of Cancer. 2015;137(7):1729-1738. https://doi.org/10.1002/ijc.29534